Assessing Vancomycin Dosing Per Pharmacy in Elderly Patients Over the Age of 74 Years | Zendy

Lee Nguyen | Zendy; Martin Breen | Zendy; Jason Yamaki | Zendy; Geraldine Cadalin | Zendy; Linda Lumintaintang | Zendy; Nilomi Shah | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Assessing Vancomycin Dosing Per Pharmacy in Elderly Patients Over the Age of 74 Years

Author(s) -

Lee Nguyen,

Martin Breen,

Jason Yamaki,

Geraldine Cadalin,

Linda Lumintaintang,

Nilomi Shah

Publication year - 2018

Publication title -

journal of contemporary pharmacy practice

Language(s) - English

Resource type - Journals

eISSN - 2573-2765

pISSN - 2573-2757

DOI - 10.37901/jcphp17-00014

Subject(s) - vancomycin , dosing , medicine , creatinine , nephrotoxicity , trough concentration , ototoxicity , pharmacy , pharmacokinetics , trough level , renal function , pediatrics , toxicity , chemotherapy , transplantation , family medicine , biology , bacteria , genetics , staphylococcus aureus , tacrolimus , cisplatin

Vancomycin has a complex pharmacokinetic profile and carries potential risks for nephrotoxicity and ototoxicity. The pharmacokinetic profile in elderly patients significantly differs from that of younger patients. It is common practice in many institutions for pharmacists to intentionally round serum creatinine levels to 1 mg/dl in elderly patients with levels <1 mg/ dl to avoid overestimating clearance and toxicities. This can potentially lead to underestimation of creatinine clearance, and subsequently lead to vancomycin under dosing. The aim of this study was to evaluate vancomycin target trough attainment and the time to trough attainment with vancomycin dosing per pharmacy in elderly patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research